How to use early biomarkers to help determine whether or not to perform imaging against a human target or a possible human subject to head injury

摘要

In this specificationUbiquitin carboxyl terminal hydrolase L1 (uc-l1)Using early biomarkers such as glial fibrillary acidic protein (GFAP) or combinations thereofDamaged by the headOr, for a possible human targetDisclosed is a method of determining whether to perform imaging such as magnetic resonance imaging (MRI) or head computed tomography (CT) scans.These methods involve detecting changes in the level and level of UCH-L1 in the samples collected from the human object at a point within 24 hours after the object has suffered or damaged.